Treatment Information

Back

Mesothelioma treatment details. Chemotherapy.

Erasmus Medical Center, Rotterdam, Netherlands.

Survival: monthsCountry:Netherlands
Toxiciy Grade:4City/State/Province:Rotterdam
Treatments:ChemotherapyHospital:Erasmus Medical Center
Drugs:Journal:Link
Date:Apr 2002

Description:

Patients: This Phase II study involved 27 patients with malignant pleural mesothelioma. None of these patients had been administered prior chemotherapy.

Treatment: The treatment consisted of the chemotherapy drug, temozolomide (temodar).

Toxicity: Grade 3-4 toxicities included hematologic, infection, nausea, vomiting, and arthralgia.

Results: The median overall survival from the time the patient registered in the study was 8.2 months.

Support: Schering-Plough International supported this study. Schering-Plough markets temodar.

Correspondence: J.P. van Meerbeeck




Back